<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 64-yr-old patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), with refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> subtype following <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> exposure received immunosuppressive treatment with antithymocyte globulin and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> (CsA) </plain></SENT>
<SENT sid="1" pm="."><plain>Complete remission was achieved and CsA was tapered after 2.5 yr </plain></SENT>
<SENT sid="2" pm="."><plain>Shortly after CsA withdrawal, the patient relapsed with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> but responded to restoration of CsA </plain></SENT>
<SENT sid="3" pm="."><plain>This case illustrates that immune-mediated mechanisms of cytopenia in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may be dependent on continued immunosuppressive treatment similar to <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>